News + Filings Holdings
All
13F
13D/G
Other
|
|
AGTC ADVISORS FUND LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2015 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/29/2015 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on BG Medicine, Inc.|
Txns:
| Sold 206 shares
@ $2.27, valued at
$467.6
Sold 16 shares
@ $2.27, valued at
$36.3
Sold 32 shares
@ $2.27, valued at
$72.6
Exercised (in-or-at-the-money) 3,256 options to buy
@ $0.14, valued at
$455.8
Exercised (in-or-at-the-money) 254 options to buy
@ $0.14, valued at
$35.6
Exercised (in-or-at-the-money) 508 options to buy
@ $0.14, valued at
$71.1 |
|
| 07/16/2015 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on BG Medicine, Inc.|
Txns:
| Acquired options to buy
@ $0
Converted options to buy
@ $0
Converted 183,971 options to buy
@ $0
Bought 725,725 options to buy
@ $1.7003, valued at
$1.2M
Converted 13,553 options to buy
@ $0
Bought 53,465 options to buy
@ $1.7003, valued at
$90.9k
Acquired options to buy
@ $0
Converted options to buy
@ $0
Converted 100,657 options to buy
@ $0
Bought 397,072 options to buy
@ $1.7003, valued at
$675.1k
|
|
| 05/26/2015 |
SC 13D/A
| AGTC ADVISORS FUND LP reports a 15.5% stake in BG Medicine, Inc. |
| 02/01/2013 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on BG Medicine, Inc.|
Txns:
| Bought 250,000 shares
@ $2, valued at
$500k
Bought 125,000 shares
@ $2, valued at
$250k
Bought 75,000 shares
@ $2, valued at
$150k
Bought 500,000 shares
@ $2, valued at
$1M
Bought 1,050,000 shares
@ $2, valued at
$2.1M
|
|
| 02/11/2011 |
4
| AGTC Partners, L.P. (10% Owner) has filed a Form 4 on BG Medicine, Inc.|
Txns:
| Converted 125,725 shares
@ $0
Converted 3 shares
@ $7, valued at
$21
Bought 14,285 shares
@ $7, valued at
$100k
Converted 2,079,975 shares
@ $0
Converted 43 shares
@ $7, valued at
$301
Bought 271,429 shares
@ $7, valued at
$1.9M
Converted 366,933 preferred shares
@ $0
Converted 6,070,468 preferred shares
@ $0
Converted 38,083 preferred shares
@ $0
Converted 630,026 preferred shares
@ $0
Converted convertible notes
@ $7, valued at
$0 |
|
| 02/03/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 12/09/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/22/2009 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/05/2009 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/29/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2008 |
SC 13G
| AGTC ADVISORS FUND LP reports a 15.9% stake in HELICOS BIOSCIENCES CORPORATION |
|
|